Published in Atherosclerosis on April 01, 1987
Changes in the atherogenic risk factor profile according to degree of weight loss. Arch Dis Child (2004) 1.88
Implementing a state-based cardiovascular disease and diabetes prevention program. Diabetes Care (2010) 1.07
High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease. Vasc Health Risk Manag (2008) 0.97
Women and obesity. Learning to live with it. Can Fam Physician (1993) 0.75
Moderate weight reduction in an outpatient obesity intervention program significantly reduces insulin resistance and risk factors for cardiovascular disease in severely obese adolescents. Int J Endocrinol (2011) 0.75
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods (1999) 17.06
Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain. Obes Rev (2005) 5.72
Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet (2001) 3.60
Flaws in methods of evidence-based medicine may adversely affect public health directives. Surgery (2005) 3.49
The predictive validity of body mass index based on self-reported weight and height. Int J Obes (1989) 2.65
Risk factors for ischaemic heart-disease in normal men aged 40. Edinburgh-Stockholm Study. Lancet (1978) 2.32
Reduced food intake after jejunoileal bypass: a possible association with prolonged gastric emptying and altered gut hormone patterns. Am J Clin Nutr (1997) 2.27
Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol (2000) 2.24
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int J Obes (Lond) (2011) 2.08
Quality of alternative medicine--complications and avoidable deaths. Qual Assur Health Care (1990) 2.00
Weight development over time in parous women--the SPAWN study--15 years follow-up. Int J Obes Relat Metab Disord (2003) 1.78
Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors. Diabetologia (1994) 1.73
Maternal body weight development after pregnancy. Int J Obes (1990) 1.72
Night eating and nocturnal eating-two different or similar syndromes among obese patients? Int J Obes Relat Metab Disord (2001) 1.63
Weight maintenance after a very low calorie diet (VLCD) weight reduction period and the effects of VLCD supplementation. A prospective, randomized, comparative, controlled long-term trial. J Intern Med (1995) 1.58
Long-term effects of a very low calorie diet (Nutrilett) in obesity treatment. A prospective, randomized, comparison between VLCD and a hypocaloric diet+behavior modification and their combination. Int J Obes Relat Metab Disord (1997) 1.58
Effects of early discharge from hospital after surgery for primary breast cancer. Eur J Surg (1993) 1.54
Trends in eating patterns, physical activity and socio-demographic factors in relation to postpartum body weight development. Br J Nutr (1994) 1.54
Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance. Obes Rev (2000) 1.53
Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord (1999) 1.41
Obesity treatment and attrition: no relationship to obesity level. Obes Res (1996) 1.39
Long-term weight development after pregnancy. Obes Rev (2002) 1.35
Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr (1998) 1.32
Prevalence of obesity in Sweden. Obes Rev (2006) 1.28
An android body fat distribution in females impairs the pregnancy rate of in-vitro fertilization-embryo transfer. Hum Reprod (1997) 1.28
Is walking for exercise too exhausting for obese women? Int J Obes Relat Metab Disord (1997) 1.23
Factors related to body weight changes during and after pregnancy: the Stockholm Pregnancy and Weight Development Study. Obes Res (1996) 1.21
Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro. Eur J Immunol (2000) 1.21
Predictive value of early weight loss in obesity management with orlistat: an evidence-based assessment of prescribing guidelines. Int J Obes Relat Metab Disord (2003) 1.20
The Christmas factor in obesity therapy. Int J Obes Relat Metab Disord (1992) 1.16
Eating behaviour in obese and normal weight 11-year-old children. Int J Obes Relat Metab Disord (1992) 1.15
Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes. Diabetes Obes Metab (2007) 1.14
Normal serum-cholesterol but low H.D.L.-cholesterol concentration in young patients with ischaemic cerebrovascular disease. Lancet (1978) 1.12
Gastroesophageal reflux in obese patients is not reduced by weight reduction. Scand J Gastroenterol (1996) 1.11
Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis. Obes Rev (2009) 1.10
Social mapping of the obesity epidemic in Sweden. Int J Obes Relat Metab Disord (2000) 1.08
The sense of coherence concept and its relation to personality traits in Swedish samples. Scand J Caring Sci (1992) 1.06
Predialysis education helps patients choose dialysis modality and increases disease-specific knowledge. J Adv Nurs (1999) 1.05
Disability pension, employment and obesity status: a systematic review. Obes Rev (2008) 1.05
Barriers to and facilitators of research utilization, as perceived by a group of registered nurses in Sweden. J Adv Nurs (1998) 1.05
The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions. Clin Exp Immunol (1993) 1.05
An Internet-based weight loss programme -- a feasibility study with preliminary results from 4209 completers. Scand J Public Health (2008) 1.05
Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen. Atherosclerosis (1984) 1.03
Lifelong treatment with gammaglobulin for primary antibody deficiencies: the patients' experiences of subcutaneous self-infusions and home therapy. J Adv Nurs (1995) 1.02
Increased physical activity in abdominally obese women through support for changed commuting habits: a randomized clinical trial. Int J Obes (Lond) (2009) 1.02
Clinical and metabolic effects of pentaerythritol tetranicotinate(Perycit)and a comparison with plain nicotinic acid. Atherosclerosis (1974) 1.01
Sexual function in obese women: impact of lower urinary tract dysfunction. Int J Obes (Lond) (2008) 1.01
Randomized, multi-center trial of two hypo-energetic diets in obese subjects: high- versus low-fat content. Int J Obes (Lond) (2006) 1.01
Long term treatment of severe obesity: four year follow up of results of combined behavioural modification programme. Br Med J (Clin Res Ed) (1985) 1.00
Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success. Diabetes Obes Metab (2007) 0.99
Effects of a high-protein meal (meat) and a high-carbohydrate meal (vegetarian) on satiety measured by automated computerized monitoring of subsequent food intake, motivation to eat and food preferences. Int J Obes (1990) 0.99
Serum lipoprotein changes during atenolol treatment of essential hypertension. Eur J Clin Pharmacol (1981) 0.98
Discrepancies between classification systems of childhood obesity. Obes Rev (2004) 0.98
Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance. Int J Obes Relat Metab Disord (2001) 0.98
Eating behavior in Prader-Willi syndrome, normal weight, and obese control groups. J Pediatr (2000) 0.97
Well-being and its relation to coping ability in patients with colo-rectal and gastric cancer before and after surgery. Scand J Caring Sci (1996) 0.96
Beta-blockers and running. Am Heart J (1980) 0.96
Coping ability and functional status in a Swedish population sample. Scand J Caring Sci (1993) 0.96
Increase of intra-abdominal fat in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int (1998) 0.96
Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial. Diabetes Obes Metab (2005) 0.95
Excessive fat accumulation is associated with the TNF alpha-308 G/A promoter polymorphism in women but not in men. Diabetologia (2000) 0.95
Prevalence of obesity in Sweden: cross-sectional study of a representative adult population. J Intern Med (1990) 0.94
Safety of rapid subcutaneous gammaglobulin infusions in patients with primary antibody deficiency. Immunodeficiency (1993) 0.93
Long-term changes in blood pressure following orlistat and sibutramine treatment: a meta-analysis. Obes Rev (2010) 0.92
Melatonin secretion related to side-effects of beta-blockers from the central nervous system. Acta Med Scand (1988) 0.92
The "true" prevalence of obesity. A comparison of objective weight and height measures versus self-reported and calibrated data. Scand J Prim Health Care (1989) 0.91
Swedish population norms for the GHRI, HI and STAI-state. Qual Life Res (1993) 0.91
Macronutrient-specific effect of FTO rs9939609 in response to a 10-week randomized hypo-energetic diet among obese Europeans. Int J Obes (Lond) (2009) 0.91
Neuropeptides of the autonomic nervous system in Sjögren's syndrome. Ann Rheum Dis (1997) 0.91
Medical education in the Nordic countries. Nord Med (1974) 0.90
Effects of an oral contraceptive agent on plasma lipids, plasma lipoproteins, the intravenous fat tolerance and the post-heparin lipoprotein lipase activity. Acta Med Scand (1971) 0.90
The criterion validity of a last 7-day physical activity questionnaire (SAPAQ) for use in adolescents with a wide variation in body fat: the Stockholm Weight Development Study. Int J Obes (Lond) (2006) 0.89
Intake of sweet foods and counts of cariogenic microorganisms in relation to body mass index and psychometric variables in women. Int J Obes Relat Metab Disord (2002) 0.89
[Salutogenic model and utilization of the KASAM form (Sense of Coherence) in nursing research--a methodological report]. Vard Nord Utveckl Forsk (1996) 0.88
Predialysis patient education: effects on functioning and well-being in uraemic patients. J Adv Nurs (1998) 0.88
Agglutinate formation in serum samples mixed with intravenous fat emulsions. Crit Care Med (1985) 0.88
Sense of coherence and outcome of anterior low-back fusion. A 5- to 13-year follow-up of 85 patients. Arch Orthop Trauma Surg (1996) 0.87
Personality traits predicting weight loss outcome in obese patients. Acta Psychiatr Scand (1986) 0.87
Eating habits in relation to body fatness and gender in adolescents--results from the 'SWEDES' study. Eur J Clin Nutr (2006) 0.87
Meal patterns in obese and normal weight men: the 'Gustaf' study. Eur J Clin Nutr (1996) 0.87
Quality of life in predialytic uremic patients. Qual Life Res (1996) 0.87
A ten-year follow-up of weight change in severely obese subjects treated in a combined behavioural modification programme. Int J Obes Relat Metab Disord (1992) 0.86
Changes in high density lipoprotein subfractions and other lipoproteins by exercise. Clin Chim Acta (1981) 0.86
Dyslipoproteinaemia in patients with active, chronic polyarthritis. A study on serum lipoproteins and triglyceride clearance (intravenous fat tolerance test). Atherosclerosis (1977) 0.86
Long-term physical training in female type 1 (insulin-dependent) diabetic patients: absence of significant effect on glycaemic control and lipoprotein levels. Diabetologia (1986) 0.86
Functional status and coping in patients with oral and pharyngeal cancer before and after surgery. Head Neck (1995) 0.85
Post-traumatic stress symptoms in patients undergoing autologous stem cell transplantation. Acta Oncol (1999) 0.85
Short-term effects of sibutramine (Reductil) on appetite and eating behaviour and the long-term therapeutic outcome. Int J Obes Relat Metab Disord (2003) 0.85
Effects of weight reduction on the regulation of lipolysis in adipocytes of women with upper-body obesity. Clin Sci (Lond) (1995) 0.85
Plasma concentrations of regulatory peptides in obesity following modified sham feeding (MSF) and a liquid test meal. Regul Pept (1992) 0.85
Effects of milk or water on lunch intake in preschool children. Appetite (1998) 0.84
Cutting edge: resistance to apoptosis and continuous proliferation of dendritic cells deficient for TNF receptor-1. J Immunol (2000) 0.84
Body weight characteristics of subjects on asthma medication. Int J Obes Relat Metab Disord (2000) 0.84
The Gustaf study: repeated, telephone-administered 24-hour dietary recalls of obese and normal-weight men--energy and macronutrient intake and distribution over the days of the week. J Am Diet Assoc (1996) 0.84
Fatty acid composition in serum lipids and adipose tissue in severe obesity before and after six weeks of weight loss. Int J Obes (1989) 0.84
Influence of body image on estimation of body mass index based on self-reported weight and height. Diabetes Res Clin Pract (1990) 0.84